Aegerion Pharmaceuticals Inc (AEGR)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mary J. Szela
Employees:
318
ONE MAIN STREET, SUITE 800, CAMBRIDGE, MA 02142
(617) 500-7867

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States.

Data derived from most recent annual or quarterly report
Market Cap 58.204 Million Shares Outstanding29.545 Million Avg 30-day Volume 335.467 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from AEGR instead.

View recent insider trading info

Funds Holding AEGR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AEGR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GOTTO ANTONIO M JR MD D PHIL

  • Director
No longer subject to file 2016-11-29 0

THOMAS PAUL

  • Director
No longer subject to file 2016-11-29 0

VANLENT ANNE

  • Director
No longer subject to file 2016-11-29 0

PERRY GREGORY D

  • SEE REMARKS
No longer subject to file 2016-11-29 0

SMITH SANDFORD D

  • Director
No longer subject to file 2016-11-29 0

BARER SOL J

  • Director
No longer subject to file 2016-11-29 0

SCHEER DAVID

  • Director
No longer subject to file 2016-11-29 0

SZELA MARY T CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2016-11-29 0

BROADFIN HEALTHCARE MASTER FUND LTD

BROADFIN CAPITAL, LLC

KOTLER KEVIN

  • 10% Owner
No longer subject to file 2016-11-29 0

PLUTZKY JORGE MD

  • Director
No longer subject to file 2016-11-29 0

STERN DONALD K

  • Director
No longer subject to file 2016-11-29 0

HARSHBARGER BENJAMIN GENERAL COUNSEL AND SECRETARY

  • Officer
No longer subject to file 2016-11-29 0

LOUIS ROGER CHIEF COMPLIANCE OFFICER

  • Officer
No longer subject to file 2016-11-29 0

CHAN BARBARA Y VP, CHIEF ACCOUNTING OFFICER

  • Officer
No longer subject to file 2016-11-29 0

BUONO LINDA SR. VP, HUMAN RESOURCES

  • Officer
No longer subject to file 2016-11-29 0

ORLOFF JOHN J EVP, RESEARCH AND DEVELOPMENT

  • Officer
0 2016-11-01 0

MENES REMI A GLOBAL CHIEF COMMERCIAL OFF.

  • Officer
0 2016-09-12 0

QLT INC/BC

  • 10% Owner
0 2016-06-14 0

CARTER MARTHA J. SEE REMARKS

  • Officer
0 2016-05-09 0

CURTIS ERIC PRESIDENT, U.S. COMMERCIAL

  • Officer
0 2015-08-26 0

COOK ANNE MARIE SVP, GENERAL COUNSEL

  • Officer
0 2015-08-04 0

SUMERAY MARK CHIEF MEDICAL OFFICER

  • Officer
0 2015-08-04 0

ANDREWS WILLIAM T. SEE REMARKS

  • Officer
0 2015-08-04 0

WEGER MARY CHIEF PERFORMANCE OFFICER

  • Officer
0 2015-08-04 0

AUBUCHON DAVID CHIEF FINANCIAL OFFICER

  • Officer
0 2015-06-05 0

BEER MARC D CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2015-04-01 0

FITZPATRICK MARK J. CHIEF FINANCIAL OFFICER

  • Officer
0 2015-04-01 0

FRASER CRAIG CHIEF OPERATING OFFICER

  • Officer
0 2015-04-01 0

PERCEPTIVE ADVISORS LLC

EDELMAN JOSEPH

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

  • 10% Owner
No longer subject to file 2013-06-15 0

ALTA BIOPHARMA PARTNERS III LP

PENHOET EDWARD

CHAMPSI FARAH

HURWITZ EDWARD

ALTA BIOPHARMA MANAGEMENT III LLC

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

KILEY ALISON

  • 10% Owner
No longer subject to file 2012-10-15 0

ROTHERA MARK GLOBAL PRESIDENT

  • Officer
0 2012-05-01 0

ADVENT INTERNATIONAL CORP/MA

  • MEMBER OF GROUP > 10%
2,457,879 2012-03-09 0

ADVENT INTERNATIONAL LLC

  • MEMBER OF GROUP > 10%
2,430,765 2012-03-09 0

AHLS III GP LIMITED PARTNERSHIP

  • MEMBER OF GROUP > 10%
2,430,765 2012-03-09 0

ADVENT HEALTHCARE & LIFE SCIENCES III LIMITED PARTNERSHIP

  • MEMBER OF GROUP > 10%
985,052 2012-03-09 0

ADVENT PARTNERS HLS III LIMITED PARTNERSHIP

  • MEMBER OF GROUP > 10%
27,114 2012-03-09 0

ADVENT HEALTHCARE & LIFE SCIENCES III-A LIMITED PARTNERSHIP

  • MEMBER OF GROUP > 10%
1,445,713 2012-03-09 0

INDEX VENTURE ASSOCIATES III LTD

INDEX VENTURES III (DELAWARE) L.P.

INDEX VENTURES III (JERSEY) L.P.

INDEX VENTURES III PARALLEL ENTREPRENEUR FUND (JERSEY) L.P.

YUCCA PARTNERS L.P. JERSEY BRANCH

  • 10% Owner
No longer subject to file 2012-01-30 0

ALTA BIOPHARMA PARTNERS III LP

PENHOET EDWARD

CHAMPSI FARAH

HURWITZ EDWARD

ALTA BIOPHARMA MANAGEMENT III LLC

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

  • 10% Owner
2,741,272 2011-08-08 0

KILEY ALISON

  • Director
  • 10% Owner
2,690,251 2011-08-08 0

OLLIER MICHELE

  • Director
  • 10% Owner
2,131,827 2011-07-29 0

TRIBBLE DIANE L. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2011-03-01 0

FISHERMAN JASON S

  • Director
7,848 2010-10-27 0

ALTA BIOPHARMA PARTNERS III LP

ALTA BIOPHARMA MANAGEMENT III LLC

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

DELEAGE JEAN

CHAMPSI FARAH

PENHOET EDWARD

HURWITZ EDWARD

  • 10% Owner
60,502 2010-10-27 0

LEWIS WILLIAM PRESIDENT, PFO AND TREASURER

  • Officer
412,761 2010-10-27 0

PELLIZZARI CHRISTINE A EVP, GEN. COUNSEL & SECRETARY

  • Officer
0 2010-10-21 0

SCHEER INVESTMENT HOLDINGS VII LLC

  • DIRECTOR IS MANAGING MEMBER
640,154 2010-10-21 0

CAVAN JOHN T VP & CHIEF ACCOUNTING OFFICER

  • Officer
0 2010-10-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments